Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies

The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create EcoRI (E +, E −) and XbaI (X +, X −) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E +X +, E +X −, E −X + and E −X − in the normolipidaemic popu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 1988, Vol.69 (1), p.39-49
Hauptverfasser: Jenner, Kris, Sidoli, Alessandro, Ball, Madeline, Rodriguez, Jose R., Pagani, Franco, Giudici, G., Vergani, Carlo, Mann, Jim, Baralle, Francisco E., Shoulders, Carol C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 49
container_issue 1
container_start_page 39
container_title Atherosclerosis
container_volume 69
creator Jenner, Kris
Sidoli, Alessandro
Ball, Madeline
Rodriguez, Jose R.
Pagani, Franco
Giudici, G.
Vergani, Carlo
Mann, Jim
Baralle, Francisco E.
Shoulders, Carol C.
description The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create EcoRI (E +, E −) and XbaI (X +, X −) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E +X +, E +X −, E −X + and E −X − in the normolipidaemic population are 0.68, 0.30, 0.02 and 0.00, respectively. Although the polymorphic nucleotide underlying the EcoRI RFLP creates an amino acid substitution in the apo B protein (Glu → Lys) in a region close to a putative LDL-receptor recognition site(s), we find no statistically significant difference in the frequency of the apo B Glu and apo B Lys alleles in hyperlipidaemic patients (familial hypercholesterolaemia, type IIA with no tendon xanthomas, IIB and probably IV) and the normolipidaemic population. In contrast, we confirm previous findings, that the X + allele is in linkage disequilibrium with a genetic locus that predisposes to the development of higher fasting plasma triglyceride levels than the X − allele. We have characterized a highly polymorphic region immediately 3′ to the apo B gene. At least 5 alleles of this locus exist in the population and our family studies show it should be an extremely informative locus to use in studies where polymorphic or mutant apo B alleles are suspected to underly certain forms of familial hyperlipidaemia. DNA sequence analysis of this highly polymorphic locus shows that the variation is entirely attributable to the number of times the simple repeating sequence 5′-TTTATAATTAAAATATTTATAATTAAATAT-3′ is present.
doi_str_mv 10.1016/0021-9150(88)90287-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78156362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0021915088902870</els_id><sourcerecordid>78156362</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-cf1985fef5993144a93eaa4744f2cf13d2e1dc17a1a7885164b85be4356374f3</originalsourceid><addsrcrecordid>eNp9kMFu1DAURS1EVYaBPwDJC4RgkWInduxsKsEIaKWR2HRvvXGeqSGTBNtBKqt-Uz-JL6kzE82yK8v3nnf13iXkDWcXnPH6E2MlLxou2QetPzas1Kpgz8iKa9UUXGjxnKxOyAvyMsZfjDGhuD4n56VuZC3ViqTNLQSwCYP_B8kPPR0c_Yk9Jm_pHsJvDJH6nqZbpNX_-weKfTsj8x_GgX45wBSymiUf6BRx5h3sfXd30MdhnLpjdkxT6zG-ImcOuoivl3dNbr59vdlcFdsf3683n7eFrXSdCut4o6VDJ5um4kJAUyGAUEK4MntVWyJvLVfAQWkteS12Wu5QVLKulHDVmrw_xo5h-DNhTGbvo8Wugx6HKRqleSbrMoPiCNowxBjQmTH4fPyd4czMXZu5SDMXabQ2h64Ny2Nvl_xpt8f2NLSUm_13iw_RQucC9NbHE6a0yHfJjF0eMcxV_PUYTLQee4utD2iTaQf_9B6PueebSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78156362</pqid></control><display><type>article</type><title>Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Jenner, Kris ; Sidoli, Alessandro ; Ball, Madeline ; Rodriguez, Jose R. ; Pagani, Franco ; Giudici, G. ; Vergani, Carlo ; Mann, Jim ; Baralle, Francisco E. ; Shoulders, Carol C.</creator><creatorcontrib>Jenner, Kris ; Sidoli, Alessandro ; Ball, Madeline ; Rodriguez, Jose R. ; Pagani, Franco ; Giudici, G. ; Vergani, Carlo ; Mann, Jim ; Baralle, Francisco E. ; Shoulders, Carol C.</creatorcontrib><description>The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create EcoRI (E +, E −) and XbaI (X +, X −) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E +X +, E +X −, E −X + and E −X − in the normolipidaemic population are 0.68, 0.30, 0.02 and 0.00, respectively. Although the polymorphic nucleotide underlying the EcoRI RFLP creates an amino acid substitution in the apo B protein (Glu → Lys) in a region close to a putative LDL-receptor recognition site(s), we find no statistically significant difference in the frequency of the apo B Glu and apo B Lys alleles in hyperlipidaemic patients (familial hypercholesterolaemia, type IIA with no tendon xanthomas, IIB and probably IV) and the normolipidaemic population. In contrast, we confirm previous findings, that the X + allele is in linkage disequilibrium with a genetic locus that predisposes to the development of higher fasting plasma triglyceride levels than the X − allele. We have characterized a highly polymorphic region immediately 3′ to the apo B gene. At least 5 alleles of this locus exist in the population and our family studies show it should be an extremely informative locus to use in studies where polymorphic or mutant apo B alleles are suspected to underly certain forms of familial hyperlipidaemia. DNA sequence analysis of this highly polymorphic locus shows that the variation is entirely attributable to the number of times the simple repeating sequence 5′-TTTATAATTAAAATATTTATAATTAAATAT-3′ is present.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/0021-9150(88)90287-0</identifier><identifier>PMID: 2895657</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ireland Ltd</publisher><subject>Adult ; Apo B genetic markers ; Apolipoproteins B - genetics ; Base Sequence ; Biological and medical sciences ; Disorders of blood lipids. Hyperlipoproteinemia ; Female ; Genetic Markers ; Haplotypes ; Humans ; Hyperlipidaemia ; Hyperlipoproteinemia Type II - genetics ; Hypervariable region ; Male ; Medical sciences ; Metabolic diseases ; Molecular Sequence Data ; Mutation ; Pedigree ; Polymorphism, Genetic ; Polymorphism, Restriction Fragment Length</subject><ispartof>Atherosclerosis, 1988, Vol.69 (1), p.39-49</ispartof><rights>1988</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-cf1985fef5993144a93eaa4744f2cf13d2e1dc17a1a7885164b85be4356374f3</citedby><cites>FETCH-LOGICAL-c386t-cf1985fef5993144a93eaa4744f2cf13d2e1dc17a1a7885164b85be4356374f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0021-9150(88)90287-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,4009,27902,27903,27904,45974</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7849935$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2895657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jenner, Kris</creatorcontrib><creatorcontrib>Sidoli, Alessandro</creatorcontrib><creatorcontrib>Ball, Madeline</creatorcontrib><creatorcontrib>Rodriguez, Jose R.</creatorcontrib><creatorcontrib>Pagani, Franco</creatorcontrib><creatorcontrib>Giudici, G.</creatorcontrib><creatorcontrib>Vergani, Carlo</creatorcontrib><creatorcontrib>Mann, Jim</creatorcontrib><creatorcontrib>Baralle, Francisco E.</creatorcontrib><creatorcontrib>Shoulders, Carol C.</creatorcontrib><title>Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create EcoRI (E +, E −) and XbaI (X +, X −) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E +X +, E +X −, E −X + and E −X − in the normolipidaemic population are 0.68, 0.30, 0.02 and 0.00, respectively. Although the polymorphic nucleotide underlying the EcoRI RFLP creates an amino acid substitution in the apo B protein (Glu → Lys) in a region close to a putative LDL-receptor recognition site(s), we find no statistically significant difference in the frequency of the apo B Glu and apo B Lys alleles in hyperlipidaemic patients (familial hypercholesterolaemia, type IIA with no tendon xanthomas, IIB and probably IV) and the normolipidaemic population. In contrast, we confirm previous findings, that the X + allele is in linkage disequilibrium with a genetic locus that predisposes to the development of higher fasting plasma triglyceride levels than the X − allele. We have characterized a highly polymorphic region immediately 3′ to the apo B gene. At least 5 alleles of this locus exist in the population and our family studies show it should be an extremely informative locus to use in studies where polymorphic or mutant apo B alleles are suspected to underly certain forms of familial hyperlipidaemia. DNA sequence analysis of this highly polymorphic locus shows that the variation is entirely attributable to the number of times the simple repeating sequence 5′-TTTATAATTAAAATATTTATAATTAAATAT-3′ is present.</description><subject>Adult</subject><subject>Apo B genetic markers</subject><subject>Apolipoproteins B - genetics</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Disorders of blood lipids. Hyperlipoproteinemia</subject><subject>Female</subject><subject>Genetic Markers</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Hyperlipidaemia</subject><subject>Hyperlipoproteinemia Type II - genetics</subject><subject>Hypervariable region</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Pedigree</subject><subject>Polymorphism, Genetic</subject><subject>Polymorphism, Restriction Fragment Length</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFu1DAURS1EVYaBPwDJC4RgkWInduxsKsEIaKWR2HRvvXGeqSGTBNtBKqt-Uz-JL6kzE82yK8v3nnf13iXkDWcXnPH6E2MlLxou2QetPzas1Kpgz8iKa9UUXGjxnKxOyAvyMsZfjDGhuD4n56VuZC3ViqTNLQSwCYP_B8kPPR0c_Yk9Jm_pHsJvDJH6nqZbpNX_-weKfTsj8x_GgX45wBSymiUf6BRx5h3sfXd30MdhnLpjdkxT6zG-ImcOuoivl3dNbr59vdlcFdsf3683n7eFrXSdCut4o6VDJ5um4kJAUyGAUEK4MntVWyJvLVfAQWkteS12Wu5QVLKulHDVmrw_xo5h-DNhTGbvo8Wugx6HKRqleSbrMoPiCNowxBjQmTH4fPyd4czMXZu5SDMXabQ2h64Ny2Nvl_xpt8f2NLSUm_13iw_RQucC9NbHE6a0yHfJjF0eMcxV_PUYTLQee4utD2iTaQf_9B6PueebSw</recordid><startdate>1988</startdate><enddate>1988</enddate><creator>Jenner, Kris</creator><creator>Sidoli, Alessandro</creator><creator>Ball, Madeline</creator><creator>Rodriguez, Jose R.</creator><creator>Pagani, Franco</creator><creator>Giudici, G.</creator><creator>Vergani, Carlo</creator><creator>Mann, Jim</creator><creator>Baralle, Francisco E.</creator><creator>Shoulders, Carol C.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1988</creationdate><title>Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies</title><author>Jenner, Kris ; Sidoli, Alessandro ; Ball, Madeline ; Rodriguez, Jose R. ; Pagani, Franco ; Giudici, G. ; Vergani, Carlo ; Mann, Jim ; Baralle, Francisco E. ; Shoulders, Carol C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-cf1985fef5993144a93eaa4744f2cf13d2e1dc17a1a7885164b85be4356374f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Apo B genetic markers</topic><topic>Apolipoproteins B - genetics</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Disorders of blood lipids. Hyperlipoproteinemia</topic><topic>Female</topic><topic>Genetic Markers</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Hyperlipidaemia</topic><topic>Hyperlipoproteinemia Type II - genetics</topic><topic>Hypervariable region</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Pedigree</topic><topic>Polymorphism, Genetic</topic><topic>Polymorphism, Restriction Fragment Length</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jenner, Kris</creatorcontrib><creatorcontrib>Sidoli, Alessandro</creatorcontrib><creatorcontrib>Ball, Madeline</creatorcontrib><creatorcontrib>Rodriguez, Jose R.</creatorcontrib><creatorcontrib>Pagani, Franco</creatorcontrib><creatorcontrib>Giudici, G.</creatorcontrib><creatorcontrib>Vergani, Carlo</creatorcontrib><creatorcontrib>Mann, Jim</creatorcontrib><creatorcontrib>Baralle, Francisco E.</creatorcontrib><creatorcontrib>Shoulders, Carol C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jenner, Kris</au><au>Sidoli, Alessandro</au><au>Ball, Madeline</au><au>Rodriguez, Jose R.</au><au>Pagani, Franco</au><au>Giudici, G.</au><au>Vergani, Carlo</au><au>Mann, Jim</au><au>Baralle, Francisco E.</au><au>Shoulders, Carol C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>1988</date><risdate>1988</risdate><volume>69</volume><issue>1</issue><spage>39</spage><epage>49</epage><pages>39-49</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create EcoRI (E +, E −) and XbaI (X +, X −) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E +X +, E +X −, E −X + and E −X − in the normolipidaemic population are 0.68, 0.30, 0.02 and 0.00, respectively. Although the polymorphic nucleotide underlying the EcoRI RFLP creates an amino acid substitution in the apo B protein (Glu → Lys) in a region close to a putative LDL-receptor recognition site(s), we find no statistically significant difference in the frequency of the apo B Glu and apo B Lys alleles in hyperlipidaemic patients (familial hypercholesterolaemia, type IIA with no tendon xanthomas, IIB and probably IV) and the normolipidaemic population. In contrast, we confirm previous findings, that the X + allele is in linkage disequilibrium with a genetic locus that predisposes to the development of higher fasting plasma triglyceride levels than the X − allele. We have characterized a highly polymorphic region immediately 3′ to the apo B gene. At least 5 alleles of this locus exist in the population and our family studies show it should be an extremely informative locus to use in studies where polymorphic or mutant apo B alleles are suspected to underly certain forms of familial hyperlipidaemia. DNA sequence analysis of this highly polymorphic locus shows that the variation is entirely attributable to the number of times the simple repeating sequence 5′-TTTATAATTAAAATATTTATAATTAAATAT-3′ is present.</abstract><cop>Amsterdam</cop><pub>Elsevier Ireland Ltd</pub><pmid>2895657</pmid><doi>10.1016/0021-9150(88)90287-0</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 1988, Vol.69 (1), p.39-49
issn 0021-9150
1879-1484
language eng
recordid cdi_proquest_miscellaneous_78156362
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
Apo B genetic markers
Apolipoproteins B - genetics
Base Sequence
Biological and medical sciences
Disorders of blood lipids. Hyperlipoproteinemia
Female
Genetic Markers
Haplotypes
Humans
Hyperlipidaemia
Hyperlipoproteinemia Type II - genetics
Hypervariable region
Male
Medical sciences
Metabolic diseases
Molecular Sequence Data
Mutation
Pedigree
Polymorphism, Genetic
Polymorphism, Restriction Fragment Length
title Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A23%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20genetic%20markers%20in%20the%203%E2%80%B2%20end%20of%20the%20apo%20B%20gene%20and%20their%20use%20in%20family%20and%20population%20studies&rft.jtitle=Atherosclerosis&rft.au=Jenner,%20Kris&rft.date=1988&rft.volume=69&rft.issue=1&rft.spage=39&rft.epage=49&rft.pages=39-49&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/0021-9150(88)90287-0&rft_dat=%3Cproquest_cross%3E78156362%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78156362&rft_id=info:pmid/2895657&rft_els_id=0021915088902870&rfr_iscdi=true